In contrast, activity of the TGFβ pathway was frequently lost in advanced prostate cancer and in esophageal cancer, suggestive of a tumor suppressive role in the corresponding healthy tissue (Creemers et al., 2018; van de Stolpe et al., 2019a). The gene discussed is TGFB1; the disease is esophageal cancer.